Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Cambrex Charles City, Inc | Charles City, IA, United States | Makes the active ingredient | Problems found, fixed voluntarilyMar 7, 2025 · 8 inspections |
| Curia New York, Inc. | Rensselaer, NY, United States | Makes the active ingredient and tests it | Serious problems, FDA actionFeb 5, 2026 · 8 inspections, 1 with FDA action |
| Patheon Pharmaceuticals Inc. | Cincinnati, OH, United States | Makes it, tests it and packages it | Problems found, fixed voluntarilySep 26, 2025 · 15 inspections |
Recalls
- Sep 2, 2016 · Class III · Shire
Presence of Foreign Tablets/Capsules
Lots: Lot # AF3360B; Exp. 04/19
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lisdexamfetamine: every company that makes it
- Form
- tablet, chewable, oral
- Strength
- 40 mg
- Approval
- NDA NDA208510
- On the market since
- Jan 28, 2017
- Package NDCs
59417-118-01- Official label
- DailyMed (National Library of Medicine), updated Apr 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?